Porphyromonas gingivalis accelerates neointimal formation after arterial injury

Journal of Vascular Research

Volumn 49, Issue 5, 2012, Pages 417-424

  Kobayashi, Naho ^a   Suzuki, Jun Ichi ^a,b   Ogawa, Masahito ^a,b   Aoyama, Norio ^a   Hanatani, Tomoya ^a   Hirata, Yasunobu ^a   Nagai, Ryozo ^a   Izumi, Yuichi ^a   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arterial injury; Matrix metalloproteinases; Neointima; Porphyromonas gingivalis

Indexed keywords

GELATINASE A; MESSENGER RNA; PHOSPHATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; CONTROLLED STUDY; FEMORAL ARTERY; HISTOPATHOLOGY; MOUSE; NEOINTIMA; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BACTEROIDACEAE INFECTIONS; FEMORAL ARTERY; MALE; MATRIX METALLOPROTEINASE 2; MICE; NEOINTIMA; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; TUNICA INTIMA;

EID: 84862742759     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000339583     Document Type: Article

References (48)

1. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA: Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004;109:2801-2806. (Pubitemid 38737928)
2. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W: Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 2006;166:554-559.
3. Janket SJ, Baird AE, Chuang SK, Jones JA: Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:559-569. (Pubitemid 36886703)
4. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ: Identification of periodontal pathogens in atheromatous plaques. J Periodontol 2000;71:1554-1560.
5. Fiehn NE, Larsen T, Christiansen N, Holmstrup P, Schroeder TV: Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 2005;76:731-736. (Pubitemid 40852385)
6. D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS: Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006;151:977-984.
7. Rajasuo A, Perkki K, Nyfors S, Jousimies-Somer H, Meurman JH: Bacteremia following surgical dental extraction with an emphasis on anaerobic strains. J Dent Res 2004;83:170-174. (Pubitemid 41713804)
8. Heimdahl A, Hall G, Hedberg M, Sandberg H, Soder PO, Tuner K, Nord CE: Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol 1990;28:2205-2209. (Pubitemid 20299108)
9. Conner HD, Haberman S, Collings CK, Winford TE: Bacteremias following periodontal scaling in patients with healthy appearing gingiva. J Periodontol 1967;38:466-472.
10. Debelian GJ, Olsen I, Tronstad L: Bacteremia in conjunction with endodontic therapy. Endod Dent Traumatol 1995;11:142-149.
11. Savarrio L, Mackenzie D, Riggio M, Saunders WP, Bagg J: Detection of bacteremias during non-surgical root canal treatment. J Dent 2005;33:293-303. (Pubitemid 40386851)
12. Tonetti MS: Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol 2009;36(suppl 10):15-19.
13. Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE: Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 2003;71:6012-6018. (Pubitemid 37205654)
14. Yamamoto Y, Watari Y, Brydun A, Yoshizumi M, Akishita M, Horiuchi M, Chayama K, Oshima T, Ozono R: Role of the angiotensin II type 2 receptor in arterial remodeling after wire injury in mice. Hypertens Res 2008;31:1241-1249.
15. Greenlee KJ, Corry DB, Engler DA, Matsunami RK, Tessier P, Cook RG, Werb Z, Kheradmand F: Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 2006;177:7312-7321. (Pubitemid 44715101)
16. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT: Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 2000;106:55-62. (Pubitemid 30437240)
17. Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM, Lowry AS, Escobar GP, Lucas DG, Yarbrough WM, Zile MR, Spinale FG: Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 2003;107:618-625. (Pubitemid 36176814)
18. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503. (Pubitemid 24379627)
19. Ogawa M, Suzuki J, Hishikari K, Takayama K, Tanaka H, Isobe M: Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51:1977-1985. (Pubitemid 351636452)
20. Lijnen HR, Soloway P, Collen D: Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice. Circ Res 1999;85:1186-1191. (Pubitemid 30430624)
21. Tavakoli S, Razavian M, Zhang J, Nie L, Marfatia R, Dobrucki LW, Sinusas AJ, Robinson S, Edwards DS, Sadeghi MM: Matrix metalloproteinase activation predicts amelioration of remodeling after dietary modification in injured arteries. Arterioscler Thromb Vasc Biol 2011;31:102-109.
22. Aoyama N, Suzuki J, Wang D, Ogawa M, Kobayashi N, Hanatani T, Takeuchi Y, Izumi Y, Isobe M: Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res 2011;46:176-183.
23. Suzuki J, Ogawa M, Muto S, Yamaguchi Y, Itai A, Isobe M: The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury. Expert Opin Ther Targets 2008;12:783-794. (Pubitemid 352003320)
24. Inagaki H, Suzuki J, Ogawa M, Taniyama Y, Morishita R, Isobe M: Ultrasound-microbubblemediated NF-kappaB decoy transfection attenuates neointimal formation after arterial injury in mice. J Vasc Res 2006;43:12-18. (Pubitemid 41832706)
25. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y, Nagai R: A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32:2097-2104.
26. Ogawa M, Suzuki J, Kosuge H, Takayama K, Nagai R, Isobe M: The mechanism of antiinflammatory effects of prostaglandin E 2 receptor 4 activation in murine cardiac transplantation. Transplantation 2009;87:1645-1653.
27. Lyons SR, Griffen AL, Leys EJ: Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol 2000;38:2362-2365. (Pubitemid 30414365)
28. Li L, Messas E, Batista EL Jr, Levine RA, Amar S: Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105:861-867. (Pubitemid 34174928)
29. Meurman JH, Sanz M, Janket SJ: Oral health, atherosclerosis, and cardiovascular disease. Crit Rev Oral Biol Med 2004;15:403-413. (Pubitemid 44567524)
30. Houri-Haddad Y, Soskoine WA, Shapira L: Immunization to Porphyromonas gingivalis enhances the local pro-inflammatory response to subcutaneous bacterial challenge. J Clin Periodontol 2001;28:476-482. (Pubitemid 33755467)
31. Lin D, Smith MA, Champagne C, Elter J, Beck J, Offenbacher S: Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 2003;71:5156-5162. (Pubitemid 37070759)
32. Lin YY, Huang JH, Lai YY, Huang HC, Hu SW: Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation. Infect Immun 2005;73:7946-7952.
33. Holt SC, Kesavalu L, Walker S, Genco CA: Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999;20:168-238.
34. Grenier D, La VD: Proteases of Porphyromonas gingivalis as important virulence factors in periodontal disease and potential targets for plant-derived compounds: a review article. Curr Drug Targets 2011;12:322-331.
35. Belanger M, Kozarov E, Song H, Whitlock J, Progulske-Fox A: Both the unique and repeat regions of the Porphyromonas gingivalis hemagglutin A are involved in adhesion and invasion of host cells. Anaerobe 2011;18:128-134.
36. Zhang MZ, Li CL, Jiang YT, Jiang W, Sun Y, Shu R, Liang JP: Porphyromonas gingivalis infection accelerates intimal thickening in iliac arteries in a balloon-injured rabbit model. J Periodontol 2008;79:1192-1199.
37. Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, Yamamoto Y, Masuda T, Umemoto T, Kitano S: Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993;61:5219-5224. (Pubitemid 23353901)
38. Stark VK, Hoch JR, Warner TF, Hullett DA: Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. Arterioscler Thromb Vasc Biol 1997;17:1614-1621. (Pubitemid 27387785)
39. Furukawa Y, Matsumori A, Ohashi N, Shioi T, Ono K, Harada A, Matsushima K, Sasayama S: Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 1999;84:306-314. (Pubitemid 29095571)
40. Kang IC, Kuramitsu HK: Induction of monocyte chemoattractant protein-1 by Porphyromonas gingivalis in human endothelial cells. FEMS Immunol Med Microbiol 2002;34:311-317. (Pubitemid 35351382)
41. Bodet C, Chandad F, Grenier D: Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol 2006;143:50-57.
42. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW: Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 1997;96:3555-3560. (Pubitemid 27513433)
43. Johnson JL, Dwivedi A, Somerville M, George SJ, Newby AC: Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol 2011;31:e35-e44.
44. Zou Y, Qi Y, Roztocil E, Davies MG: Patterns of gelatinase activation induced by injury in the murine femoral artery. J Surg Res 2009;154:135-142.
45. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002;91:852-859. (Pubitemid 35285084)
46. Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, Rayburn LA, Tran HM, Singh AK, Giannobile WV: Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-446.
47. Soder PO, Meurman JH, Jogestrand T, Nowak J, Soder B: Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2009;44:452-458.
48. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R: Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis. J Clin Periodontol 2001;28:353-359. (Pubitemid 33761346)